stars 1 stars 2 stars 3

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. For U.S. residents only.

Immunovant Questions

The Immunovant annual revenue was $43.7 million in 2026.

Eric Venker is the CEO of Immunovant.

224 people are employed at Immunovant.

Immunovant is based in New York, New York.

The NAICS codes for Immunovant are [325, 3254, 32, 32541].

The SIC codes for Immunovant are [283, 28].

Top Immunovant Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users